Kiana Aran

Kiana Aran is an Associate Professor of Bioengineering at the University of California San Diego, with a joint appointment in the School of Medicine. Her research focuses on the development of bioelectronic technologies for multi-omics analysis, targeted drug delivery, and aging research, integrating engineering, molecular biology, and clinical translation. Her lab pioneers the convergence of CRISPR technologies with electronic systems to enhance genotyping accuracy, gene editing quality control, and precision therapeutic interventions. She also serves as Co-Director of the Center for Technologies for Healthy Aging at UC San Diego and actively contributes to national science and engineering policy through programs such as New Voices of the National Academies. In addition to academic research, she has founded and co-founded multiple biotechnology companies, including Cardea Bio and CRISPR QC, translating bioelectronic innovations into commercial and clinical impact. Her work has been widely recognized with numerous awards across engineering, biotechnology, and innovation, reflecting her role in advancing interdisciplinary bioengineering and precision medicine.